Jaschevatzky O E, David H, Bivas M, Rosenberg R P, Ellenbogen A, Ballas S
Department of Obstetrics and Gynecology, Hillel Jaffe Medical Center, Hadera, Israel.
J Perinat Med. 1994;22(4):351-5.
The purpose of this prospective study was to investigate the outcome of pregnancies associated with marked gestational thrombocytopenias (< 100,000/mm3) including postpartum resolution and neonatal influence. Over a period of 18 months, 20 cases of thrombocytopenia were observed; of them 19 were diagnosed as gestational thrombocytopenia with platelet values of < 100,000/mm3. Fifteen women returned to a normal platelet count within two weeks after delivery and four within four weeks. No cases of thrombocytopenia were found among the infants and no cases of coagulation disturbance were observed in the mothers at delivery or in the postpartum period. The findings of the present study indicate that in cases of gestational thrombocytopenia, apart from a careful maternal and fetal surveillance, no intervention is necessary during pregnancy or delivery if there is no obstetrical indication.
这项前瞻性研究的目的是调查与显著妊娠期血小板减少症（<100,000/mm³）相关的妊娠结局，包括产后血小板计数恢复情况及对新生儿的影响。在18个月的时间里，观察到20例血小板减少症病例；其中19例被诊断为妊娠期血小板减少症，血小板值<100,000/mm³。15名女性在分娩后两周内血小板计数恢复正常，4名在四周内恢复正常。婴儿中未发现血小板减少症病例，母亲在分娩时或产后期间也未观察到凝血障碍病例。本研究结果表明，对于妊娠期血小板减少症病例，除了进行仔细的母胎监测外，如果没有产科指征，在妊娠期间或分娩时无需干预。
